A transplant using a donor’s stem cells

When you have a transplant using another person’s stem cells, it is called an allogeneic transplant. It's more usual to have stem cells collected from the donor’s bloodstream. But some donors might have stem cells collected from their bone marrow. 

Some people might have stem cells from donated umbilical cord blood. But this is not as commonly used.

Why you might have a donor transplant

Your medical team look at a number of factors to decide whether you have a donor transplant. These include: 

  • your type of cancer
  • what other treatments you have had
  • your general health
  • whether your medical team can find a suitable donor or match

Stages of a donor transplant

There are different steps or stages of an allogeneic transplant:

  • preparation
  • finding a donor
  • conditioning treatment
  • stem cell collection from your donor
  • you have your donor's stem cells
Stages of a donor stem cell transplant


To prepare for your transplant, you have:

  • various tests
  • a central line put in

The central line can stay in your vein for many months. So you don't need to have needles in your hand or arm each time you have treatment. You can also have anti sickness medicines and antibiotics through your central line. And your nurses can take blood samples from your line.

Diagram showing a central line

As part of your preparation, you might have chemotherapy to get rid of as many cancer cells as possible.


Your treatment could mean it is difficult to become pregnant or father a child in the future. Talk to your healthcare team if this is a concern for you. You might be able to store sperm or eggs before starting treatment.

Treatment can cause an early menopause in some women. Sometimes it is possible for women to freeze their eggs or embryos before cancer treatment. But it takes time to stimulate your ovaries to collect the eggs. Your doctor may not want you to delay starting cancer treatment.

Men may be able to bank sperm before starting any treatment.

Ask your doctor and nurse if you're not sure about anything. They can explain what your options are. 

Finding a donor

Ideally, your donated stem cells need to match your own. A brother or sister is most likely to be a close match.

Sometimes, if you don't have a brother or sister who is a match, you can have stem cells from a donor. This could be a donor who is not related to you but whose stem cells are similar to yours. This is called a matched unrelated donor (MUD) transplant.  

Some people might have stem cells that are not a perfect match (but partly match). This is called a mismatched transplant.

To make sure that your donor's cells match, you and your donor have blood tests.

Laboratory staff check the surface of your blood cells and the donor blood cells for certain proteins. The proteins are called HLA markers or histocompatibility antigens. So the test is called HLA typing or tissue typing.

Everyone has their own set of proteins. Staff compare the proteins on the cells in the blood samples to see if the HLA markers are the same or very similar. Usually 10 HLA markers are checked.

The results of your blood test and the donor's test tell your doctor how good the HLA match is between you. Members of your close family (such as your brother or sister) are most likely to have similar proteins to yours.

A mismatched transplant is when you have donor stem cells that partly match. For example, the donor might be at least an 80 to 90% match with you.

With a mismatched transplant, you are more likely to have a reaction afterwards. The reaction is called graft versus host disease (GvHD). This means the immune cells from the donated stem cells attack some of your body cells.

GvHD typically causes skin rashes, diarrhoea and liver damage. You have anti rejection drugs to help stop it developing. GvHD can be severe and even life threatening for some people. 

But mild GvHD can also be helpful for some people. It is an immune system reaction and can help to kill off any cancer cells left after your treatment.

Your doctor may consider a half matched transplant (haplo identical transplant). This means the donor is at least a 50% match with you. This could be one of your parents, a sibling or your child.

In the past, these transplants have been difficult to do. This was because of the increased risk of severe GvHD and infection. But doctors are finding new ways of improving this type of transplant and reducing the risk of GvHD.

You might have a stem cell transplant using stem cells from umbilical cord blood. 

In some hospitals, a woman can donate their umbilical cord and placenta. Soon after birth, a doctor takes blood from the cord and placenta, which is very rich in stem cells.  

The stem cells in the cord blood are still tested to find a good match. But cord blood does not have to match closely to be successful.

Cord transplants are mostly used for children. This is because cord blood contains a smaller number of cells. Adults could have a stem cell transplant from 2 different umbilical cords. This is called a double cord transplant. You might have cord blood stem cells as part of a clinical trial.


Once a donor is found, you have conditioning treatment. There are different drugs and regimes. What you have depends on your individual circumstances. There are also different strengths of conditioning treatment. The 2 main types are:

  • full intensity (myeloablative) conditioning
  • reduced intensity conditioning (RIC)

Full intensity conditioning (MAC)

Your doctor might also call this myeloablative conditioning or MAC. You have very high doses of chemotherapy. This is the more traditional transplant. When stem cell transplants were first developed, this was the type of conditioning that everyone had. With MAC, all of the cancer cells and healthy cells are destroyed. Your doctor might recommend you have MAC if you are young and you have certain types of cancer. For example, if you have acute leukaemia.

As well as chemotherapy, you might also have:

  • targeted drugs
  • radiotherapy to the whole body (total body irradiation or TBI)

You usually have TBI at the beginning or at the end of your chemotherapy.

Reduced intensity conditioning (RIC)

With RIC you have lower doses of chemotherapy. Some healthy cells and cancer cells are left behind after treatment has finished. You might have RIC if you are not fit or well enough for full intensity conditioning. This is now the standard conditioning treatment for most types of cancer. You might also have targeted drugs with your chemotherapy.

RIC can have fewer side effects. But there is a greater risk of the cancer coming back, compared to MAC. Even though the doses of chemotherapy are lower, this can still be a difficult treatment to cope with. Your healthcare team monitor you closely through your treatment and when you go home. 

Conditioning treatment can take about 7 days. But it could be shorter or longer depending on the drugs you have.

Stem cell collection from your donor

Donors usually have stem cells collected from their bloodstream. When this happens, your donor has growth factor injections once a day for 4 days. The growth factor makes the stem cells spill out into their bloodstream. When there are enough stem cells, these are collected through a drip from their bloodstream.

Some donors have stem cells taken from their bone marrow. Your donor has a general anaesthetic for this. A doctor then puts a needle into their hip bone to remove the bone marrow. 

The Anthony Nolan charity has more information for donors and what is involved.

You have your donor’s stem cells

After you have your chemotherapy and other treatments you have your donor’s stem cells. You have these through your central line into your bloodstream.

Photograph showing a stem cell transplant

Hospital stay

After conditioning treatment, you have low numbers of blood cells for some time. This means you are at risk of getting infections. You usually stay in hospital until:

  • your blood cells have recovered enough to go home
  • you no longer have any severe side effects 

This might take 4 or 5 weeks following a donor transplant, although this time can vary from one person to another. 


You might have a single room in the hospital ward to help protect you from infection. Your medical team might call this being in isolation. 

While you are in isolation you can have visitors, but your nurses may suggest that you only have one or two each day. Your friends and relatives should not come to see you if they are not well. Or if they have been in contact with anyone with an infectious disease.

You might need to follow a special diet including foods that are unlikely to give you an infection. 

Coping with isolation

Staying in a single room in hospital can feel lonely. Some people find it frightening. It can help to talk to the nurses about your worries. They can reassure you. 

Taking in some of your personal things can make the room feel more homely. Books and photos can brighten it up. You can also take in a laptop, tablet, mobile and music. This can help the time to pass and you can keep in touch with friends and family. 

Blood count recovery

Your donor stem cells find their way into your bone marrow where they make the blood cells you need. You have regular blood tests to check when your bone marrow starts to make new blood cells. This recovery of blood cells is called engraftment. 

During this time, you continue to have treatment for any side effects and symptoms. This might include:

  • antibiotics and antiviral medicines to treat and prevent infection
  • platelet transfusions if the number of platelets in your blood is low
  • blood transfusions if your red blood cells are low
  • medicines to relieve a sore mouth, diarrhoea and sickness


Your doctor measures the proportion of cells that are from your donor. After RIC, it is normal at first to have some of your donor stem cells and some of your own cells. This is called mixed chimerism. Eventually, all your blood and bone marrow should ideally be from your donor. This is called full chimerism. 

You have tests to check for chimerism every few months for about a year after your transplant.  

Donor lymphocyte infusion (DLI)

Lymphocytes are a type of white blood cell. They are part of the immune system.

You might have some of your donor’s lymphocytes as a drip into your bloodstream. Increasing the amount of donor cells helps the immune system get rid of any of your remaining cells. So eventually you have full donor chimerism. You are more likely to need donor lymphocyte infusions if you have a transplant following RIC. Some people might need quite a few of these infusions. Other people may not need any. 

You usually have donor lymphocyte infusions after you go home and as an outpatient. 

Side effects of transplants

Side effects of a donor transplant include:

  • increased risk of getting an infection 
  • tiredness and lacking energy
  • increased risk of bleeding
  • sickness and diarrhoea
  • The European Blood and Marrow Transplantation Textbook for Nurses. Under the Auspices of EBMT

    M Kenyon and A. Babic 

    Springer Open, 2018

  • British Society of Blood and Marrow Transplantation Indications for BMT
    British Society of Blood and Marrow Transplantation, 2013

  • Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years
    J Passweg and others
    Bone Marrow Transplantation, 2021. Volume 56, pages 1651-1664

  • Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols
    R Hough and others
    British Journal of Haematology, 2016. Volume 172, pages 360–370

  • BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation
    A-M Little and others
    International Journal of Immuogenetics, 2021. Volume 48, pages 75-109

  • The information on this page is based on literature searches and specialist checking. We used many references and there are too many to list here. Please contact patientinformation@cancer.org.uk with details of the particular issue you are interested in if you need additional references for this information.

Last reviewed: 
29 Nov 2022
Next review due: 
29 Nov 2025

Related links